David Polinsky Insider Profile
11 Followers
David Polinsky, Director at Eterna Therapeutics, holds ― shares in Eterna Therapeutics (Ticker: ERNA), holds 299.11K shares in Rafael Holdings (Ticker: RFL), holds 699.65K shares in Innovative Food Holdings (Ticker: IVFH). Most recently, David Polinsky ― shares of Eterna Therapeutics on ― for an estimated value of ―.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-19.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Polinsky holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Polinsky
David Polinsky's Trading History
Eterna Therapeutics
―
Director
―
―
Innovative Food Holdings
Mar 25, 2020
Director
Uninformative Buy
8.50K
$153.92K
Rafael Holdings
Jun 23, 2026
CFO
Uninformative Sell
6.28K
$681.97K
List of latest transactions for each holding click on a transaction to see David Polinsky's performance on stock
You May Also Like
David Polinsky insider profile FAQ
What is the percentage of profitable transactions made by David Polinsky?
The percentage of profitable transactions made by David Polinsky is 0%.
What is the average return per transaction made by David Polinsky?
The average return per transaction made by David Polinsky is -19.90%.
What stocks does David Polinsky hold?
David Polinsky holds: ERNA, IVFH, RFL stocks.
What was David Polinsky’s latest transaction?
David Polinsky latest transaction was an Uninformative Buy of ―.
What was David Polinsky's most profitable transaction?
David Polinsky’s most profitable transaction was an Informative Buy of RFL stock on May 30, 2025. The return on the trade was -4.10%.
What is David Polinsky's role in Eterna Therapeutics?
David Polinsky's role in Eterna Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.